Patents by Inventor Shigeto Fujishita

Shigeto Fujishita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL COMPOUND USEFUL AS TOLL-LIKE RECEPTOR 7 ACTIVATION INHIBITOR
    Publication number: 20230234944
    Abstract: CB-7 exhibits a weak TLR7 inhibiting effect in normal mice. The present invention provides a novel compound with a stronger TLR7 inhibiting effect than CB-7, a pharmaceutically acceptable salt of said compound, or a prodrug of said compound or salt. The present invention also provides a drug for the prevention or treatment of diseases associated with the activation of TLR7, said drug including the aforementioned TLR7 activation inhibitor.
    Type: Application
    Filed: June 7, 2021
    Publication date: July 27, 2023
    Inventors: Yoshinori NAGAI, Naoki OKAMOTO, Shigeto FUJISHITA, Takatsugu HIROKAWA
  • EXTERNAL PREPARATION
    Publication number: 20180311225
    Abstract: The present invention provides an external preparation that exerts excellent allergy treatment effects and comprises a combination of at least one ingredient (A) selected from the group consisting of ketotifen and pharmaceutically acceptable salts thereof; and at least one component (B) selected from the group consisting of quinolone antibacterial agents, saccharides, and inorganic salts.
    Type: Application
    Filed: October 28, 2016
    Publication date: November 1, 2018
    Inventors: Takahito KIMURA, Shigeto FUJISHITA, Satoshi SHIOTA, Kenji ASO, Hitoshi OIDA, Isao HORIUCHI
  • Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same
    Patent number: 9326979
    Abstract: An object of the invention is to provide a transdermal absorption preparation capable of sustaining the blood morphine concentration at an effective level over at least 48 hours, etc.
    Type: Grant
    Filed: February 29, 2008
    Date of Patent: May 3, 2016
    Assignee: TEIKA PHARMACEUTICAL CO., LTD.
    Inventors: Takahito Kimura, Masahiro Orihashi, Shigeto Fujishita, Koichi Takabatake, Tatsuhisa Kato, Satoshi Shiota, Yuichiro Shima
  • Remedy for corneal diseases
    Patent number: 8318739
    Abstract: The present invention provides a method for treating a corneal disease by administering to a patient in need of such treatment an effective amount of ozagrel or a salt thereof.
    Type: Grant
    Filed: July 1, 2010
    Date of Patent: November 27, 2012
    Assignee: Teika Pharmaceutical Co., Ltd.
    Inventors: Takahito Kimura, Shigeto Fujishita, Hiroyoshi Kawada
  • Therapeutic agent for corneal disease
    Patent number: 8268824
    Abstract: A therapeutic agent for a corneal disease comprising irsogladine or a salt thereof as an active ingredient. The purpose is to find a substance capable of effectively treating/ameliorating a corneal disease which has been increased in the number of cases thereof in recent years and to provide a therapeutic agent for a corneal disease comprising the substance as an active ingredient.
    Type: Grant
    Filed: January 12, 2010
    Date of Patent: September 18, 2012
    Assignee: Teika Pharmaceutical Co., Ltd.
    Inventors: Takahito Kimura, Shigeto Fujishita, Hiroyoshi Kawada
  • REMEDY FOR CORNEAL DISEASES
    Publication number: 20100267665
    Abstract: The present invention provides a method for treating a corneal disease by administering to a patient in need of such treatment an effective amount of ozagrel or a salt thereof.
    Type: Application
    Filed: July 1, 2010
    Publication date: October 21, 2010
    Applicant: TEIKA PHARMACEUTICAL CO., LTD.
    Inventors: Takahito Kimura, Shigeto Fujishita, Hiroyoshi Kawada
  • THERAPEUTIC AGENT FOR CORNEAL DISEASE
    Publication number: 20100113456
    Abstract: A therapeutic agent for a corneal disease comprising irsogladine or a salt thereof as an active ingredient. The purpose is to find a substance capable of effectively treating/ameliorating a corneal disease which has been increased in the number of cases thereof in recent years and to provide a therapeutic agent for a corneal disease comprising the substance as an active ingredient.
    Type: Application
    Filed: January 12, 2010
    Publication date: May 6, 2010
    Applicant: TEIKA PHARMACEUTICAL CO., LTD.
    Inventors: Takahito Kimura, Shigeto Fujishita, Hiroyoshi Kawada
  • MEDICINAL COMPOSITION FOR TRANSDERMAL ABSORPTION, MEDICINAL COMPOSITION STORING UNIT AND TRANSDERMAL ABSORPTION PREPARATION USING THE SAME
    Publication number: 20100074943
    Abstract: An object of the invention is to provide a transdermal absorption preparation capable of sustaining the blood morphine concentration at an effective level over at least 48 hours, etc.
    Type: Application
    Filed: February 29, 2008
    Publication date: March 25, 2010
    Applicant: TEIKA PHARMACEUTICAL CO., LTD.
    Inventors: Takahito Kimura, Masahiro Orihashi, Shigeto Fujishita, Koichi Takabatake, Tatsuhisa Kato, Satoshi Shiota, Yuichiro Shima
  • REMEDY FOR CORNEAL DISEASES
    Publication number: 20090247600
    Abstract: A therapeutic agent for a corneal disease comprising ozagrel or a salt thereof as an active ingredient is provided. The purpose is to find a substance capable of effectively treating/ameliorating a corneal disease which has been increased in the number of cases thereof in recent years and to provide a therapeutic agent for a corneal disease comprising the substance as an active ingredient.
    Type: Application
    Filed: August 24, 2006
    Publication date: October 1, 2009
    Applicant: TEIKA PHARAMACEUTICAL CO., LTD.
    Inventors: Takahito Kimura, Shigeto Fujishita, Hiroyoshi Kawada
  • THERAPEUTIC AGENT FOR CORNEAL DISEASE
    Publication number: 20090030001
    Abstract: A therapeutic agent for a corneal disease comprising irsogladine or a salt thereof as an active ingredient. The purpose is to find a substance capable of effectively treating/ameliorating a corneal disease which has been increased in the number of cases thereof in recent years and to provide a therapeutic agent for a corneal disease comprising the substance as an active ingredient.
    Type: Application
    Filed: April 27, 2006
    Publication date: January 29, 2009
    Applicant: TEIKA PHARMACEUTICAL CO., LTD.
    Inventors: Takahito Kimura, Shigeto Fujishita, Hiroyoshi Kawada